Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

DSpace Repository

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

Author: Reilmann, Ralf; Anderson, Karen E.; Feigin, Andrew; Tabrizi, Sarah J.; Leavitt, Blair R.; Stout, Julie C.; Piccini, Paola; Schubert, Robin; Loupe, Pippa; Wickenberg, Anna; Borowsky, Beth; Rynkowski, Gail; Volkinshtein, Rita; Li, Thomas; Savola, Juha-Matti; Hayden, Michael; Gordon, Mark Forrest
Tübinger Autor(en):
Reilmann, Ralf
Published in: Lancet Neurology (2024), Bd. 23, H. 3, S. 243-255
Verlagsangabe: New York : Elsevier Science Inc
Language: English
Full text: http://dx.doi.org/10.1016/S1474-4422(23)00454-4
ISSN: 1474-4422
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)